Clinical Trials
4 trialsNCT01721577 2023-05-22
AXL1717
Rush University Medical Center
Phase 1/2 Terminated
NCT01561456 2013-12-05
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Axelar AB
Phase 2 Completed
NCT01466647 2012-11-12
A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)
Axelar AB
Phase 1 Completed
NCT01062620 2011-09-15
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
Axelar AB
Phase 1 Completed